Can Levetiracetam Cause Loose Stools?
Yes, levetiracetam can cause diarrhea/loose stools, though it occurs at relatively low frequency and is generally not a major concern compared to other adverse effects.
Evidence from FDA Drug Labeling
According to the FDA prescribing information, diarrhea is listed as an adverse event that occurred in at least 5% of patients with primary generalized tonic-clonic seizures treated with levetiracetam (8% vs 7% in placebo) 1. In adult patients with partial onset seizures, diarrhea was reported but occurred at similar or lower rates compared to placebo-treated patients 1.
Clinical Context and Frequency
The gastrointestinal side effect profile of levetiracetam is relatively mild:
In pediatric patients (4-16 years) with partial onset seizures, diarrhea was not among the adverse events occurring in ≥2% of patients at higher frequency than placebo 1
In patients with primary generalized tonic-clonic seizures, diarrhea occurred in 8% of levetiracetam-treated patients versus 7% on placebo 1
A comprehensive systematic review analyzing adverse effects found that diarrhea was among the reported adverse events but was not statistically significant when compared to placebo 2
Most Common Adverse Effects to Monitor
The FDA labeling identifies the five most frequent adverse events as:
- Somnolence
- Asthenia (weakness)
- Dizziness
- Headache
- Infection
Diarrhea/loose stools ranks lower in frequency than these primary concerns 1.
Clinical Recommendations
- If diarrhea occurs, it is typically mild to moderate in intensity 1
- The adverse event does not appear to be dose-dependent based on available data
- Monitor for more concerning gastrointestinal symptoms like severe abdominal pain or signs of serious complications
- Consider other medications or medical conditions as potential contributors if diarrhea is problematic
Important Caveats
While diarrhea can occur with levetiracetam, the more clinically significant adverse effects to monitor include behavioral changes (aggression, agitation, depression), somnolence, and neuropsychiatric symptoms 1. These warrant closer attention and may require dose adjustment or discontinuation.